Acasă › Cancer metastatic › District of Columbia › Washington
Studii clinice pentru Cancer metastatic în Washington, DC
43 studii pentru Cancer metastatic caută participanți în și în jurul orașului Washington (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Study of ASP3082 in Adults With Advanced Solid Tumors
În curs de recrutareFaza 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
În curs de recrutareFaza 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
În curs de recrutareFaza 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
În curs de recrutareFaza 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Maryland Oncology Hematology, P.A., Silver Spring · La 7 mi distanță
- Maryland Oncology Hematology, P.A., Bethesda · La 7 mi distanță
- Maryland Oncology Hematology, P.A., Largo · La 11 mi distanță
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
În curs de recrutareFaza 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
În curs de recrutareFaza 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · La 7 mi distanță
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
În curs de recrutareFaza 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
În curs de recrutareFaza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
În curs de recrutareFaza 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
În curs de recrutareFaza 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · La 7 mi distanță
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
În curs de recrutareFaza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
În curs de recrutareFaza 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
În curs de recrutareFaza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
În curs de recrutareFaza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
În curs de recrutareFaza 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
În curs de recrutareFaza 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · La 7 mi distanță
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
În curs de recrutareFaza 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
În curs de recrutareFaza 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
În curs de recrutareFaza 3
- American Oncology Partners, P.A., Bethesda · La 7 mi distanță
Studying TAK-243 in Patients With Advanced Cancer
În curs de recrutareFaza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · La 7 mi distanță
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
În curs de recrutareFaza 2/3
- The Center for Cancer and Blood Disorders, Bethesda · La 7 mi distanță
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
În curs de recrutareFaza 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
În curs de recrutareFaza 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
În curs de recrutareFaza 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
În curs de recrutareFaza 1
- National Cancer Institute, Bethesda · La 7 mi distanță
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
În curs de recrutareFaza 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
În curs de recrutareFaza 1
- American Oncology Partners of Maryland, Bethesda · La 7 mi distanță
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
În curs de recrutareFaza 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Silver Spring · La 7 mi distanță
- Massive Bio SYNERGY-AI site, Bethesda · La 7 mi distanță
Studii pentru Cancer metastatic în alte orașe
- Houston, TX104 studii
- New York City, NY93 studii
- Nashville, TN70 studii
- Boston, MA63 studii
- Los Angeles, CA57 studii
- St. Louis, MO54 studii
- Arlington, VA53 studii
- Philadelphia, PA46 studii
- Chicago, IL45 studii
- San Antonio, TX44 studii
- Dallas, TX42 studii
- Seattle, WA39 studii
Alte studii în Washington
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate55 studii
- Cancer de sân46 studii
- Cancer pulmonar41 studii
- Cancer de prostată38 studii
- Obezitate33 studii
- Cancer colorectal29 studii
- Boli cardiovasculare28 studii
- Cancer de vezică urinară26 studii
- Leucemie mieloasă acută24 studii
- Cancer ovarian23 studii
- Limfom23 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.